LAUREN NUESKE: Open Payments
NPI 1003492059 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 48 payments from 10 companies in 2025. Trend: 2023 $749 · 2024 $984 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $282 |
| Janssen Biotech, Inc. | 5 | $88 |
| Aimmune Therapeutics, Inc. | 3 | $77 |
| Ipsen Biopharmaceuticals, Inc | 4 | $75 |
| Celltrion USA Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| GENZYME CORPORATION | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
Products named: RINVOQ, TREMFYA, LINZESS, ZENPEP, IQIRVO, SKYRIZI, VEGZELMA, CREON.
Industry payments across AR — which companies pay providers there.
